Short answer · Medically reviewed summary · Last updated: 2026-04-07
Ebstein’s anomaly is a rare congenital heart defect with an estimated prevalence of approximately 1 in 20,000 live births, accounting for less than 1% of all congenital heart disease cases. While often diagnosed in infancy due to severe symptoms, milder forms of Ebstein’s anomaly may remain undiagnosed until adolescence or adulthood, making exact prevalence figures difficult to determine. What is the prevalence and incidence of Ebstein’s anomaly? Ebstein’s anomaly is considered a rare condition.
Ebstein’s anomaly is a rare congenital heart defect with an estimated prevalence of approximately 1 in 20,000 live births, accounting for less than 1% of all congenital heart disease cases. While often diagnosed in infancy due to severe symptoms, milder forms of Ebstein’s anomaly may remain undiagnosed until adolescence or adulthood, making exact prevalence figures difficult to determine.
Ebstein’s anomaly is considered a rare condition. Epidemiological data from the NIH Genetic and Rare Diseases (GARD) Information Center and Orphanet suggest an incidence of approximately 1 per 20,000 live births. Because this condition involves a spectrum of severity—ranging from mild displacement of the tricuspid valve leaflets to severe heart failure—the true prevalence is likely higher than official statistics suggest, as asymptomatic individuals may never come to clinical attention. Within the DiseaseMaps.org community, 164 people with Ebstein’s anomaly have connected to share their experiences, providing a valuable real-world perspective on the diverse ways this condition manifests across different age groups.
Clinical literature generally indicates that Ebstein’s anomaly affects males and females with equal frequency. While some historical studies suggested minor variations, there is no strong evidence to support a significant gender bias. Regarding geographic or ethnic distribution, the condition is identified globally with no specific population currently known to have a significantly higher or lower risk of developing Ebstein’s anomaly. It is a sporadic condition in the vast majority of cases, meaning it occurs without a clear family history, though rare familial clusters have been documented.
Ebstein’s anomaly is a congenital condition, meaning it is present at birth. However, the age of onset for clinical symptoms varies wildly based on the anatomy of the tricuspid valve and the presence of associated defects, such as an atrial septal defect (ASD). The following factors influence when a patient is diagnosed:
The primary challenge in establishing exact prevalence is the significant clinical heterogeneity of Ebstein’s anomaly. Because the displacement of the tricuspid valve can be minimal, many individuals lead normal, active lives without ever realizing they have a cardiac anomaly. Underdiagnosis and misdiagnosis remain common, especially in regions with limited access to advanced echocardiography. As medical imaging technology improves, we are likely to see more "incidental" diagnoses of mild Ebstein’s anomaly in adults who were previously thought to be healthy.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.